Compare Globus Medical Inc. Class A Common Stock (GMED) vs Li Auto Inc (LI) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Li Auto (LI) trades at $11.75, up 3.07% today but near 52-week lows amid declining delivery volumes and negative earnings surprises. The stock shows bearish technical signals with mixed analyst sentiment (43.75% buy, 50% hold). Recent Q2 2026 results missed expectations with a net loss, though vehicle margins improved to 9.4%. New model launches (Li i9, MEGA) and global expansion plans contrast with cash burn concerns, with operating cash flow negative $8.6B in 2025.

Outlook remains challenged by intense EV competition and China's auto market slowdown, but the company's strong balance sheet ($112.8B cash) provides cushion. Analyst consensus target of $15.18 suggests 29% upside if execution improves, though near-term risks from volume pressure and margin compression persist. The stock offers value at 0.78 P/S but requires monitoring of delivery trends and cost controls.